 HAYWARD, Calif.--BUSINESS WIRE--Pulse Biosciences, Inc. Nasdaq: PLSE, a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse StimulationTM NPSTM technology, today announced that the first patient in Canada has been treated with the CellFX procedure. The first commercial use in Canada of the cellular-focused CellFX System proven to clear common benign lesions, notably sebaceous hyperplasia, seborrheic keratosis, and cutaneous non-genital warts, further e 